Compounds > colistimethate sodium
Page last updated: 2024-09-05

colistimethate sodium and piperacillin, tazobactam drug combination

colistimethate sodium has been researched along with piperacillin, tazobactam drug combination in 1 studies

Compound Research Comparison

Studies
(colistimethate sodium)		Trials
(colistimethate sodium)		Recent Studies (post-2010)
(colistimethate sodium)		Studies
(piperacillin, tazobactam drug combination)		Trials
(piperacillin, tazobactam drug combination)		Recent Studies (post-2010) (piperacillin, tazobactam drug combination)
188121401,263136914

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Crass, RL; Fitzgerald, LJ; Han, MK; Jia, S; Lenhan, BE; Lipp, MA; Patel, TS; Simon, RH1

Other Studies

1 other study(ies) available for colistimethate sodium and piperacillin, tazobactam drug combination

ArticleYear
Acute kidney injury in cystic fibrosis patients treated with intravenous colistimethate sodium or tobramycin.
    The Journal of antimicrobial chemotherapy, 2022, 08-25, Volume: 77, Issue:9

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tobramycin; Vancomycin

2022